In order to develop an immunotherapy for cancer, researchers create chimeric peptides that have antitumor activity.

Published Date: 05 Jul 2023

Pal-DMPOP, a chimeric peptide that can simultaneously block CD47/SIRP? and PD-1/PD-L1, was designed and synthesized by Professor Yanfeng Gao's team at the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

2.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

3.

In prostate cancer survivorship, sleep disturbances are underappreciated.

4.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

5.

a cutting-edge cancer diagnostic tool.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot